Henan Provincial People's Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Correlation Between Psychological Stress and Progression of Diffuse Astrocytoma Towards Secondary Glioma

Not yet recruiting

Conditions: Astrocytoma

Interventions: Other: stressors

First Posted Date: 2022-09-08

Last Posted Date: 2022-09-27

Lead Sponsor: Henan Provincial People's Hospital

Target Recruit Count: 60

Registration Number: NCT05532969

Locations: 🇨🇳
Henan Provincial People's Hospital, Zhengzhou, Henan, China

Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Astrocytoma

Phase 2

Not yet recruiting

Conditions: Astrocytoma of Brain

Interventions: Drug: Tislelizumab plus Bevacizumab

First Posted Date: 2022-08-29

Last Posted Date: 2022-09-27

Lead Sponsor: Henan Provincial People's Hospital

Target Recruit Count: 70

Registration Number: NCT05518994

Locations: 🇨🇳
Henan Provincial People's Hospital, Zhengzhou, Henan, China

Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma Patients

Not yet recruiting

Conditions: Glioblastoma

Interventions: Other: stressors

First Posted Date: 2022-08-25

Last Posted Date: 2022-09-27

Lead Sponsor: Henan Provincial People's Hospital

Target Recruit Count: 60

Registration Number: NCT05515133

Locations: 🇨🇳
Henan Provincial People's Hospital, Zhengzhou, Henan, China

Study on Gene Evolution in Glioma Under Stress Therapy

Not yet recruiting

Conditions: Genetic Change

Interventions: Drug: Gene evolution and molecular response under Bevacizumab treatment

First Posted Date: 2022-08-23

Last Posted Date: 2022-09-27

Lead Sponsor: Henan Provincial People's Hospital

Target Recruit Count: 100

Registration Number: NCT05512325

Locations: 🇨🇳
Henan Provincial People's Hospital, Zhengzhou, Henan, China

Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Oligodendroglioma

Phase 2

Recruiting

Conditions: Oligodendroglioma

Interventions: Drug: Tislelizumab plus Bevacizumab

First Posted Date: 2022-08-23

Last Posted Date: 2022-09-27

Lead Sponsor: Henan Provincial People's Hospital

Target Recruit Count: 80

Registration Number: NCT05512351

Locations: 🇨🇳
Henan Provincial People's Hospital, Zhengzhou, Henan, China

Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma

Phase 2

Not yet recruiting

Conditions: Glioblastoma

Interventions: Drug: Tislelizumab plus Bevacizumab

First Posted Date: 2022-08-16

Last Posted Date: 2022-09-27

Lead Sponsor: Henan Provincial People's Hospital

Target Recruit Count: 60

Registration Number: NCT05502991

Locations: 🇨🇳
Henan Provincial People's Hospital, Zhengzhou, Henan, China

Study on Clinical Program Optimization of Inactive Hepatitis B Surface Antigen (HBsAg) Carriers (IHCs)

Not Applicable

Recruiting

Conditions: Chronic Hepatitis B

Interventions: Behavioral: pulse therapy
Behavioral: continuous treatment

First Posted Date: 2022-07-14

Last Posted Date: 2022-07-14

Lead Sponsor: Henan Provincial People's Hospital

Target Recruit Count: 80

Registration Number: NCT05457920

Locations: 🇨🇳
Henan Provincial People's Hospital, Zhengzhou, Henan, China

Biomarkers and Postoperative Delirium in Elderly Patients

Recruiting

Conditions: Postoperative Delirium

Interventions: Behavioral: postoperative delirium

First Posted Date: 2022-07-12

Last Posted Date: 2023-01-18

Lead Sponsor: Henan Provincial People's Hospital

Target Recruit Count: 400

Registration Number: NCT05454228

Locations: 🇨🇳
Henan People's Hospital, Zhengzhou, Henan, China

Inactive HBsAg Carriers (IHCs) Treated With Pegylated Interferon α2b Based Intervention Therapy

Not Applicable

Completed

Conditions: Chronic Hepatitis B

Interventions: Drug: PegIFN α- 2b

First Posted Date: 2022-07-11

Last Posted Date: 2022-07-13

Lead Sponsor: Henan Provincial People's Hospital

Target Recruit Count: 33

Registration Number: NCT05451420

Locations: 🇨🇳
Henan Provincial People's Hospital, Zhengzhou, Henan, China

NOACs Use in AF or VTE (SUNSHINE Registry)

Recruiting

Conditions: Atrial Fibrillation
Venous Thromboembolism
Oral Anticoagulant

First Posted Date: 2022-05-18

Last Posted Date: 2022-06-09

Lead Sponsor: Henan Provincial People's Hospital

Target Recruit Count: 5000

Registration Number: NCT05378308

Locations: 🇨🇳
Henan Provincial People's Hospital, Zhengzhou, Henan, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy